A prospective, multicenter, open-label, single-arm Phase 2 study to investigate the pharmacokinetics, safety, tolerability, and exploratory efficacy of selexipag in children with pulmonary arterial hypertension
- Journal:
- Chest
- Published:
- DOI:
- 10.1016/j.chest.2025.12.013
- Affiliations:
- 5
- Authors:
- 11
| Institutions | Authors | Share |
|---|---|---|
| Johnson & Johnson, Switzerland, Switzerland | 0.73 | |
| Johnson & Johnson, Italy, Italy | 0.09 | |
| Great Ormond Street Hospital for Children (GOSH), United Kingdom (UK) | 0.09 | |
| Geneva University Hospitals (HUG), Switzerland | 0.09 |